Literature DB >> 17317350

Impact of maternal substance use during pregnancy on childhood outcome.

Seetha Shankaran1, Barry M Lester, Abhik Das, Charles R Bauer, Henrietta S Bada, Linda Lagasse, Rosemary Higgins.   

Abstract

The impact of maternal substance abuse is reflected in the 2002-2003 National Survey on Drug Use and Health. Among pregnant women in the 15-44 age group, 4.3%, 18% and 9.8% used illicit drugs, tobacco and alcohol, respectively. Maternal pregnancy complications following substance use include increases in sexually transmitted disorders, placental abruption and HIV-positive status. Effects on the neonate include a decrease in growth parameters and increases in central nervous system and autonomic nervous system signs and in referrals to child protective agencies. In childhood, behavioral and cognitive effects are seen after prenatal cocaine exposure; tobacco and alcohol have separate and specific effects. The ongoing use of alcohol and tobacco by the caretaker affects childhood behavior. Therefore, efforts should be made to prevent and treat behavioral problems as well as to limit the onset of drug use by adolescent children born to women who use drugs during pregnancy.

Entities:  

Mesh:

Year:  2007        PMID: 17317350      PMCID: PMC3717561          DOI: 10.1016/j.siny.2007.01.002

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  33 in total

1.  Neurologic soft signs and low birthweight: their association and neuropsychiatric implications.

Authors:  N Breslau; H D Chilcoat; E O Johnson; P Andreski; V C Lucia
Journal:  Biol Psychiatry       Date:  2000-01-01       Impact factor: 13.382

2.  The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.

Authors:  B M Lester; M ElSohly; L L Wright; V L Smeriglio; J Verter; C R Bauer; S Shankaran; H S Bada; H H Walls; M A Huestis; L P Finnegan; P L Maza
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

3.  Gestational cocaine exposure and intrauterine growth: maternal lifestyle study.

Authors:  Henrietta S Bada; Abhik Das; Charles R Bauer; Seetha Shankaran; Barry Lester; Linda L Wright; Joel Verter; Vincent L Smeriglio; Loretta P Finnegan; Penelope L Maza
Journal:  Obstet Gynecol       Date:  2002-11       Impact factor: 7.661

4.  The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.

Authors:  Barry M Lester; Edward Z Tronick; Linda LaGasse; Ronald Seifer; Charles R Bauer; Seetha Shankaran; Henrietta S Bada; Linda L Wright; Vincent L Smeriglio; Jing Lu; Loretta P Finnegan; Penelope L Maza
Journal:  Pediatrics       Date:  2002-12       Impact factor: 7.124

5.  The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes.

Authors:  Charles R Bauer; Seetha Shankaran; Henrietta S Bada; Barry Lester; Linda L Wright; Heidi Krause-Steinrauf; Vincent L Smeriglio; Loretta P Finnegan; Penelope L Maza; Joel Verter
Journal:  Am J Obstet Gynecol       Date:  2002-03       Impact factor: 8.661

6.  Dose-response effect of cocaine on newborn head circumference.

Authors:  D A Bateman; C A Chiriboga
Journal:  Pediatrics       Date:  2000-09       Impact factor: 7.124

7.  The search for congenital malformations in newborns with fetal cocaine exposure.

Authors:  M Behnke; F D Eyler; C W Garvan; K Wobie
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

8.  The Maternal Lifestyle Study (MLS): effects of prenatal cocaine and/or opiate exposure on auditory brain response at one month.

Authors:  Barry M Lester; Linda Lagasse; Ronald Seifer; Edward Z Tronick; Charles R Bauer; Seetha Shankaran; Henrietta S Bada; Linda L Wright; Vincent L Smeriglio; Jing Liu; Loretta P Finnegan; Penelope L Maza
Journal:  J Pediatr       Date:  2003-03       Impact factor: 4.406

9.  Health-care utilization among mothers and infants following cocaine exposure.

Authors:  Seetha Shankaran; Charles R Bauer; Henrietta S Bada; Barry Lester; Linda L Wright; Abhik Das
Journal:  J Perinatol       Date:  2003 Jul-Aug       Impact factor: 2.521

10.  Central and autonomic system signs with in utero drug exposure.

Authors:  H S Bada; C R Bauer; S Shankaran; B Lester; L L Wright; A Das; K Poole; V L Smeriglio; L P Finnegan; P L Maza
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

View more
  32 in total

1.  Neonatal outcomes and mental illness, substance abuse, and intentional injury during pregnancy.

Authors:  Anna Wiencrot; Angela Nannini; Susan E Manning; Joan Kennelly
Journal:  Matern Child Health J       Date:  2012-07

Review 2.  Neuroimaging of children following prenatal drug exposure.

Authors:  Chris Derauf; Minal Kekatpure; Nurunisa Neyzi; Barry Lester; Barry Kosofsky
Journal:  Semin Cell Dev Biol       Date:  2009-03-13       Impact factor: 7.727

Review 3.  Prenatal substance abuse: short- and long-term effects on the exposed fetus.

Authors:  Marylou Behnke; Vincent C Smith
Journal:  Pediatrics       Date:  2013-02-25       Impact factor: 7.124

Review 4.  Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.

Authors:  Xu Wang; Wen-Zhe Ho
Journal:  Life Sci       Date:  2010-11-04       Impact factor: 5.037

5.  Serial pediatric symptom checklist screening in children with prenatal drug exposure.

Authors:  Toni M Whitaker; Henrietta S Bada; Carla M Bann; Seetha Shankaran; Linda LaGasse; Barry M Lester; Charles R Bauer; Jane Hammond; Rosemary Higgins
Journal:  J Dev Behav Pediatr       Date:  2011-04       Impact factor: 2.225

6.  Association of prenatal opiate exposure with youth outcomes assessed from infancy through adolescence.

Authors:  Charles R Bauer; John Langer; Brittany Lambert-Brown; Seetha Shankaran; Henrietta S Bada; Barry Lester; Lynn L Lagasse; Toni Whitaker; Jane Hammond
Journal:  J Perinatol       Date:  2020-05-22       Impact factor: 2.521

7.  Marital status, duration of cohabitation, and psychosocial well-being among childbearing women: a canadian nationwide survey.

Authors:  Marcelo L Urquia; Patricia J O'Campo; Joel G Ray
Journal:  Am J Public Health       Date:  2012-12-13       Impact factor: 9.308

8.  An Ecodevelopmental Exploration of Mediators Between Maltreatment in Childhood and Drug use During Pregnancy.

Authors:  Steven J Ondersma; Lucy McGoron; Jessica R Beatty
Journal:  Merrill Palmer Q (Wayne State Univ Press)       Date:  2017-01

9.  Increased lymphocyte micronucleus frequency in early pregnancy is associated prospectively with pre-eclampsia and/or intrauterine growth restriction.

Authors:  D L F Furness; G A Dekker; W M Hague; T Y Khong; M F Fenech
Journal:  Mutagenesis       Date:  2010-06-25       Impact factor: 3.000

10.  Disparities in the prevalence of cognitive delay: how early do they appear?

Authors:  Marianne M Hillemeier; George Farkas; Paul L Morgan; Molly A Martin; Steven A Maczuga
Journal:  Paediatr Perinat Epidemiol       Date:  2009-01-14       Impact factor: 3.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.